Literature DB >> 17332615

Treatment of thyrotoxicosis.

Andrei Iagaru1, I Ross McDougall.   

Abstract

In this review, the causes of thyrotoxicosis and the treatment of syndromes with increased trapping of iodine are discussed. The benefits and the potential side effects of 3 frequently used therapies--antithyroid medications, thyroidectomy, and (131)I treatment--are presented. The different approaches to application of (131)I treatment are described. Treatment with (131)I has been found to be cost-effective, safe, and reliable.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17332615

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  10 in total

1.  I-131 treatment of graves' disease in an unsuspected first trimester pregnancy; the potential for adverse effects on the fetus and a review of the current guidelines for pregnancy screening.

Authors:  Phuong Tran; Shane Desimone; Mark Barrett; Bert Bachrach
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-14

2.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

3.  A NEW SIMPLE, PERSONALIZED, AND QUANTITATIVE EMPIRICAL METHOD FOR DETERMINING 131I ACTIVITY IN TREATING GRAVES' DISEASE.

Authors:  F Xu; A Gu; Y Ma
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

4.  Congenital hypothyroidism due to maternal radioactive iodine exposure during pregnancy.

Authors:  Selim Kurtoğlu; Mustafa Ali Akin; Ghaniya Daar; Leyla Akin; Seyma Memur; Levent Korkmaz; Osman Baştuğ; Selcan Yilmaz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

5.  The Incidence of Hypothyroidism Following the Radioactive Iodine Treatment of Graves' Disease and the Predictive Factors Influencing its Development.

Authors:  Maha Abd El-Kareem El-Sayed Husseni
Journal:  World J Nucl Med       Date:  2016 Jan-Apr

6.  Hypothyroidism and its associated factors after radioactive iodine therapy among patients with hyperthyroidism in the Northeast Coast State of Malaysia.

Authors:  Wan M I Wan Mohamed; Suzila C Sayuti; Nani Draman
Journal:  J Taibah Univ Med Sci       Date:  2018-07-18

7.  Eosinophil/Monocyte Ratio Combined With Serum Thyroid Hormone for Distinguishing Graves' Disease and Subacute Thyroiditis.

Authors:  Yongbin Hu; Diyi Zhou; Jiawei Chen; Pengfei Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-08       Impact factor: 5.555

8.  Radiofrequency ablation as a novel modality in the USA for treating toxic thyroid nodules: case series and literature review.

Authors:  Emad Kandil; Mahmoud Omar; Abdallah S Attia; Areej Shihabi; Mohammad Shaear; Tyler Metz; Peter P Issa; Jonathon O Russell; Ralph P Tufano
Journal:  Gland Surg       Date:  2022-09

9.  Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated 131I dose.

Authors:  Ka Kit Wong; Barry L Shulkin; Milton D Gross; Anca M Avram
Journal:  Clin Diabetes Endocrinol       Date:  2018-11-28

10.  [Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease].

Authors:  Ali Sellem; Wassim Elajmi; Rania Ben Mhamed; Nesrine Oueslati; Haroun Ouertani; Hatem Hammami
Journal:  Pan Afr Med J       Date:  2020-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.